On-demand vaccines possible with engineered nanoparticles | UW TNews

Michelle Ma

Vaccines combat diseases and protect populations from outbreaks, but the life-saving technology leaves room for improvement. Vaccines usually are made en masse in centralized locations far removed from where they will be used. They are expensive to ship and keep refrigerated and they tend to have short shelf lives.

University of Washington engineers hope a new type of vaccine they have shown to work in mice will one day make it cheaper and easy to manufacture on-demand vaccines for humans. Read More

François Baneyx Elected to the AAAS

Head shotFélicitation à François Baneyx, who was just named a fellow of the American Association for the Advancement of Science. Baneyx, professor of chemical engineering and of bioengineering and MolES faculty member, is honored for his contributions in biotechnology and biological nanotechnology. Baneyx studies protein folding and manipulates cellular pathways to make protein production simple, efficient and inexpensive. He also designs proteins that can make and assemble inorganic structures for applications ranging from vaccine production to bio-sensing and next-generation electronics. Baneyx served as director of the UW's Center for Nanotechnology from 2005 to 2013. Read More